Description

Ambroxol-TEVA (ambroxol hydrochloride) syrup 15 mg/5 ml. 100 ml

Ingredients

Ambroxol-TEVA syrup contains ambroxol hydrochloride as the active ingredient. Other ingredients include sucrose, glycerol, citric acid monohydrate, sodium benzoate, sodium cyclamate, levomenthol, raspberry flavor, and purified water.

Dosage

The recommended dosage for adults and children over 12 years old is 10 ml (30 mg) three times a day. For children aged 6-12 years, the dosage is 5 ml (15 mg) three times a day. Consult a healthcare professional for children under 6 years old.

Indications

Ambroxol-TEVA syrup is indicated for the treatment of respiratory diseases associated with viscid mucus, such as acute and chronic bronchitis, bronchial asthma, bronchiectasis, and other conditions where mucus production is a problem.

Contraindications

Do not use Ambroxol-TEVA syrup if you are allergic to ambroxol or any other ingredients in the syrup. It is also contraindicated in patients with a history of hypersensitivity to ambroxol or other similar drugs.

Directions

Shake the bottle well before use. Use the provided measuring cup to ensure accurate dosage. The syrup can be taken with or without food. Drink plenty of fluids while using Ambroxol-TEVA syrup to help loosen mucus.

Scientific Evidence

Ambroxol, the active ingredient in Ambroxol-TEVA syrup, has been extensively studied for its mucolytic and expectorant properties. Research published in the journal “Pulmonary Pharmacology & Therapeutics” demonstrated the effectiveness of ambroxol in improving mucociliary clearance and reducing mucus viscosity in patients with respiratory conditions.

Additional Information

In clinical trials, Ambroxol-TEVA syrup has shown to be well-tolerated with minimal side effects. It is considered a safe and effective option for managing respiratory conditions characterized by excessive mucus production. Consult your healthcare provider for personalized recommendations and guidance on the use of Ambroxol-TEVA syrup.

Pharmacologically, ambroxol works by stimulating the production of surfactant in the lungs, which helps in the clearance of mucus and improves respiratory function. It also exhibits antioxidant and anti-inflammatory properties, contributing to its therapeutic effects in respiratory diseases.

Compared to other mucolytic agents, ambroxol has been reported to have a rapid onset of action and a prolonged duration of effect, making it a preferred choice in the management of respiratory conditions. Its efficacy in reducing mucus viscosity and promoting mucus clearance has been well-documented in various clinical studies.